OA9 OppAlerts AI Search Visibility & Ranking Factors
oppalerts.com →
Dermatology Groups

Acne Relief Seeker

Knowledge Graph Entities
Dominant · Avg Search Engine Rank ρ=-0.444

AI recommendation signal analysis across 381 domains for the Acne Relief Seeker persona in Dermatology Groups.

Download this report (.xlsx)
381Domains Tracked
Acne Relief Seeker_persona.report
EntityScore
Mayo Clinic
60.0
Cleveland Clinic
60.0
Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation
58.2
Yale University
51.7
Skin Cancer Foundation
43.1
Entitys rankedn = 25
Want a custom AI visibility audit for Dermatology Groups?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch →
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Acne Relief Seeker. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

21K
Entities With Topic Matches
307
Entities Mentioning Brands
21K
Topic Phrase Matches
338
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

13 of 25 top domains for Acne Relief Seeker have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
aad.orgAmerican Academy of DermatologyQ4742879
curology.comNot in the knowledge graph-
schweigerderm.comSchweiger Dermatology Group (United States)Q50039797
zocdoc.comZocdocQ8073202
forefrontdermatology.comForefront of DermatologyQ30269760
apostrophe.comNot in the knowledge graph-
dermatology.orgNot in the knowledge graph-
healthgrades.comHealthGradesQ16983667
dermnetnz.orgQ136755151Q136755151
usdermatologypartners.comNot in the knowledge graph-
dermstore.comDermstoreQ21593047
epiphanydermatology.comNot in the knowledge graph-
apderm.comNot in the knowledge graph-
acne.orgNot in the knowledge graph-
aaderm.comNot in the knowledge graph-
advancedderm.comAdvanced Dermatology & Cosmetic SurgeryQ30269426
clevelandclinic.orgCleveland ClinicQ4117596
aadermatology.comNot in the knowledge graph-
webmd.comWebMDQ3536160
mayoclinic.orgMayo ClinicQ1130172
dermatologistoncall.comNot in the knowledge graph-
realself.comRealSelfQ22908167
find-a-derm.aad.orgNot in the knowledge graph-
healthline.comHealthlineQ16983671
mdacne.comNot in the knowledge graph-
25 domainsAll results shown
Wikidata

Top knowledge-graph entities

The entity records where Acne Relief Seeker's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.

EntityBlendedBrand MentionsTopic Matches
Mayo Clinic60.040
Cleveland Clinic60.040
Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation58.221
Yale University51.730
Skin Cancer Foundation43.111
CeraVe43.111
Schweiger Dermatology Group (United States)43.111
Massachusetts General Hospital41.020
The University of Texas MD Anderson Cancer Center41.020
Neutrogena41.020
American Family Physician41.020
drugs.com41.020
Northwell Health41.020
Trustpilot41.020
HealthGrades41.020
The Journal of clinical and aesthetic dermatology41.020
Harvard men's health watch41.020
Harvard women's health watch41.020
The Harvard mental health letter41.020
Forbes 30 Under 3041.020
Advanced Dermatology & Cosmetic Surgery41.020
Syosset Hospital41.020
Johns Hopkins Medicine41.020
Q9660291441.020
University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism41.020
Forbes ASAP41.020
WebMD Magazine41.020
Forbes Best-In-State Wealth Advisor41.020
Forbes Top 250 Wealth Advisor41.020
La Roche-Posay40.004
Efficacy and Tolerability of a Combined 445nm and 630nm Over-the-counter Light Therapy Mask with and without Topical Salicylic Acid versus Topical Benzoyl Peroxide for the Treatment of Mild-to-moderate Acne Vulgaris34.503
New perspectives on benzoyl peroxide use in inflammatory and comedonal acne treatment. Introduction.34.503
Skin cancer: risk to individuals using the tumour promoter benzoyl peroxide for acne treatment34.503
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris34.503
Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars34.503
Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study34.503
Clearasil27.302
skin care27.302
No7 product line27.302
Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy27.302
Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment27.302
Guidelines for the management of squamous cell carcinoma in organ transplant recipients27.302
Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne27.302
Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis27.302
Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.27.302
A simple intervention to reinforce awareness of tanning bed use and skin cancer in non‐medical skin care professionals in Southern California27.302
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne.27.302
A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne27.302
Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid27.302
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients27.302
Focal Acne Scar Treatment (FAST), a new approach to atrophic acne scars: a case series27.302
Development of the facial skin care index: a health-related outcomes index for skin cancer patients27.302
Clinical evaluation of the efficacy and safety of fractional bipolar radiofrequency for the treatment of moderate to severe acne scars27.302
Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice27.302
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study27.302
Cutaneous Safety and Tolerability of a Fixed Combination Clindamycin (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate-to-severe Acne Vulgaris27.302
The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.27.302
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey27.302
Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris27.302
Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness.27.302
Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe27.302
Results of a Multicenter, Randomized, Controlled Trial of a Hydrogen Peroxide-based Kit versus a Benzoyl Peroxide-based Kit in Mild-to-moderate Acne27.302
Papular Acne Scars of the Nose and Chin: An Under-recognised Variant of Acne Scarring27.302
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.27.302
Viral oncogenesis and its role in nonmelanoma skin cancer27.302
Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-severe Acne: An Update27.302
A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris27.302
Effects of Adapalene-Benzoyl Peroxide Combination Gel in Treatment or Maintenance Therapy of Moderate or Severe Acne Vulgaris: A Meta-Analysis27.302
Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability27.302
Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea27.302
Inflammatory Acne Treatment: Review of Current and New Topical Therapeutic Options27.302
Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender27.302
Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment27.302
Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne27.302
When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris27.302
The Use of Lipohydroxy Acid in Skin Care and Acne Treatment27.302
Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program27.302
Benzoyl peroxide gel in acne therapy27.302
Electron microscopic assay of a topical acne treatment: benzoyl peroxide acetone gel27.302
Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg27.302
Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris27.302
Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic27.302
Efficacy and tolerability of a topical gel containing 3% hydrogen peroxide, 1.5% salicylic acid and 4% D-panthenol in the treatment of mild-moderate acne27.302
Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-27.302
Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence27.302
Tolerability of a Skin Care Regimen Formulated for Acne‐Prone Skin in Children27.302
Subcision with CROSS TCA peels for moderate to severe acne scars27.302
Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/Benzoyl Peroxide 3.75% Gel.27.302
The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria27.302
Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris27.302
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.27.302
Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris27.302
Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial27.302
Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment27.302
A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face27.302
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne27.302
A study of acne treatments as risk factors for skin cancer of the head and neck27.302
Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne27.302
Efficacy and safety of stabilised hydrogen peroxide cream (Crystacide) in mild-to-moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel.27.302
Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study27.302
Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation.27.302
Prospective, Randomized, Open-Label Trial Comparing the Safety, Efficacy, and Tolerability of an Acne Treatment Regimen with and without a Probiotic Supplement and Minocycline in Subjects with Mild to Moderate Acne27.302
Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris27.302
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients27.302
Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin.27.302
'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man.27.302
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris27.302
Improving compliance in acne treatment: benzoyl peroxide considerations.27.302
Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment27.302
Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment27.302
Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris27.302
Novel device-based acne treatments: comparison of a 1450-nm diode laser and microneedling radiofrequency on mild-to-moderate acne vulgaris and seborrhoea in Korean patients through a 20-week prospective, randomized, split-face study.27.302
Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.27.302
Salicylic Acid Peel Incorporating Triethyl Citrate and Ethyl Linoleate in the Treatment of Moderate Acne: A New Therapeutic Approach27.302
What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups.27.302
Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study27.302
Efficacy of Intense-pulsed Light Therapy with Topical Benzoyl Peroxide 5% versus Benzoyl Peroxide 5% Alone in Mild-to-moderate Acne Vulgaris: A Randomized Controlled Trial27.302
Light-based inflammatory acne treatments27.302
ASSESSMENT OF THE KNOWLEDGE AND ATTITUDES OF NURSES ON THE SKIN CONDITION AND TREATMENT OF DAMAGE27.302
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne27.302
Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic27.302
Rapid treatment of mild acne with a novel skin care system containing 1% salicylic acid, 10% buffered glycolic acid, and botanical ingredients27.302
Role of activated platelets in severe acne scarring and adaptive immunity activation27.302
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison27.302
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin27.302
Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes27.302
Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long‐term treatment of predominantly moderate acne with or without concomitant medication – results from the non‐interventional cohort study ELANG27.302
A multicentre, randomized, single‐blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once‐daily gel versus clindamycin 1% twice‐daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients27.302
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel27.302
Novel retinoid ester in combination with salicylic acid for the treatment of acne27.302
Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial27.302
Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris27.302
A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin27.302
Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel27.302
2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne27.302
Effect of Samples on Acne Treatment With Epiduo® Gel27.302
The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne27.302
Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne27.302
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne27.302
Comparing OTC Acne Treatment to Prescription Regimen27.302
Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment27.302
Acne Treatment With Active Oplon's Patches - 15-18 Years Old27.302
Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)27.302
Acne Treatment With Active Oplon's Patches27.302
Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris27.302
The efficacy of glycolic acid, salicylic acid, gluconolactone, and licochalcone A combined with 0.1% adapalene vs adapalene monotherapy in mild-to-moderate acne vulgaris: a double-blinded within-person comparative study27.302
Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris27.302
A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions27.302
Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris27.302
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris27.302
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris27.302
A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris27.302
Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment27.302
A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of27.302
Combination Treatment for Moderate to Severe Acne27.302
Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid27.302
Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations27.302
A Study of Different Use Regimens Using Two Acne Treatments27.302
Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne27.302
Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris27.302
Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris27.302
Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to27.302
enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars27.302
A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics27.302
Comparison of Two Salicylic Acid Formulations27.302
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris27.302
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.27.302
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne27.302
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne27.302
A Treatment for Severe Inflammatory Acne Subjects27.302
Restylane Silk Acne Scar Efficacy Evaluation Study27.302
Therapeutic use and side effects of benzoyl peroxide in acne therapy27.302
[The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de27.302
Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle27.302
Synthetic vitamin A analogue (isotretinoin) awaiting approval for cystic acne therapy27.302
Comparative trial of benzoyl peroxide versus benzoyl peroxide with urea in inflammatory acne27.302
DAYTIME SKIN CARE AND ACNE CONTROL27.302
A "SELF-TINTING" SALICYLIC ACID AND PARACHLOROMETAXYLENOL LIQUID POWDER-BASE FOR ACNE THERAPY27.302
Observations on skin cancer in the Zwickau skin clinic27.302
A randomized, open-label, comparative study of oral doxycycline 100 mg vs. 5% topical benzoyl peroxide in the treatment of mild to moderate acne vulgaris27.302
A fixed combination of adapalene and benzoyl peroxide simplifies acne therapy27.302
Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris27.302
Prognosis of pretransplant melanoma27.302
Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel27.302
A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial27.302
Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study27.302
Melanoma in solid organ transplant recipients27.302
Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne27.302
Dermatology practice panorama. Acne treatment of Europeans especially negligent27.302
Ex vivo demonstration of a synergistic effect of Adapalene and benzoyl peroxide on inflammatory acne lesions27.302
Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne27.302
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris27.302
Development and in-vitro characterization of fish oil oleogels containing benzoyl peroxide and salicylic acid as keratolytic agents27.302
Single-center, open-label study of a proprietary topical 0.5% salicylic acid-based treatment regimen containing sandalwood oil in adolescents and adults with mild to moderate acne27.302
Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations27.302
Skin cancer screening campaigns in a Bucharest Dermatology Clinic27.302
A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne27.302
Pseudoxanthoma elasticum with peculiar acne scar of the neck: Dermoscopic features of tissue bridges as intact skin between crater-like acne scars27.302
Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence27.302
A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris27.302
Skin Delivery Aspects of Benzoyl Peroxide-Loaded Solid Lipid Nanoparticles for Acne Treatment27.302
Jessner's solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris27.302
Disparities in access to a dermatologist for acne care in the United States27.302
Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy27.302
Evaluation of Point-of-Care Decision Support for Adult Acne Treatment by Primary Care Clinicians27.302
Anti-Inflammatory Dose Doxycycline Plus Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel for Severe Acne27.302
A comparative study on the effectiveness of herbal extracts vs 2.5% benzoyl peroxide in the treatment of mild to moderate acne vulgaris27.302
Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris27.302
Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe27.302
Skin Care Management For Medical And Aesthetic Procedures To Prevent Scarring27.302
The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations27.302
A Cohort Study Using a Facial Cleansing Brush With Acne Cleansing Brush Head and a Gel Cleanser in Subjects With Mild-to-Moderate Acne and Acne-Prone Skin27.302
Acne Treatment With Light Absorbing Gold Microparticles and Optical Pulses: An Open-Label European Multi-Centered Study in Moderate to Moderately Severe Acne Vulgaris Patients27.302
Amy Forman Taub27.302
An Overview of Acne Therapy, Part 1: Topical therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions27.302
The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment27.302
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne27.302
An update on formulation strategies of benzoyl peroxide in efficient acne therapy with special focus on minimizing undesired effects27.302
The role of adolescent acne treatment in formation of scars Among patients with persistent adult acne: evidence from an observational study27.302
Prospective and randomized comparative study of calcium hydroxylapatite versus calcium hydroxylapatite plus Hifu in treatment of moderate to severe acne scars27.302
An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa27.302
A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne27.302
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris27.302
The application of skin care product in acne treatment27.302
Potential harms of long-term acne treatment with oral antibiotics27.302
A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations.27.302
Does Sensitive Skin Represent a Skin Condition or Manifestations of Other Disorders?27.302
Choosing the Right Partner: Complementing Prescription Acne Medication With Over-the-Counter Cleansers and Moisturizers27.302
Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring27.302
A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome27.302
acne treatments & kit27.302
WATER'S EDGE DERMATOLOGY27.302
LB1107 Enhancing cosmesis while achieving stellar cure rates for early stage non-melanoma skin cancer in the outpatient dermatology clinic using a novel non-invasive modality27.302
Experience with the fixed combination of benzoyl peroxide and clindamycin in acne therapy27.302
Highly sensitive determination of salicylic acid in skin care product by means of carbon nanotube/iron oxide nanoparticle voltammetric sensors27.302
Benefits of a dermocosmetic formulation with vitamins B3 and a B6 derivative combined with zinc-PCA for mild inflammatory acne and acne-prone skin27.302
336 Characterization of oral antibiotics for acne treatment27.302
Spacest.com27.302
Q13704340827.302
Cheonan Snow Clinic27.302
Siam Dermatology27.302
Clínica Hexsel de Dermatologia27.302
Q22988325.810
The World's Billionaires25.810
MedlinePlus25.810
Johns Hopkins School of Medicine25.810
Wolfgang Rindler25.810
Forbes25.810
The World's Most Powerful People25.810
Better Business Bureau25.810
Forbes Global 200025.810
Pennsylvania Hospital25.810
Mike Lazaridis25.810
Johns Hopkins Hospital25.810
Mount Sinai Hospital25.810
Walgreens25.810
polymyalgia rheumatica25.810
University of Texas at Dallas25.810
Icahn School of Medicine at Mount Sinai25.810
Lou Ruvo Center for Brain Health25.810
Mayo Clinic Hospital — Rochester25.810
The Whiffenpoofs25.810
Forbes 40025.810
Yale Literary Magazine25.810
The Yale Review25.810
WebMD25.810
Medscape25.810
Johns Hopkins All Children's Hospital25.810
American Academy of Dermatology25.810
American Academy of Family Physicians25.810
American Society of Plastic Surgeons25.810
Anxiety and Depression Association of America25.810
Arthur L. Jenkins25.810
Canyon Ranch25.810
Corinne Goldsmith Dickinson Center for Multiple Sclerosis25.810
Doximity25.810
Epocrates25.810
Harborview Medical Center25.810
Hospital of the University of Pennsylvania25.810
Howard County General Hospital25.810
Proactiv Solution25.810
Long Island Jewish Medical Center25.810
Mayo Clinic Hospital – Jacksonville25.810
NYU Langone Health25.810
Northwest Hospital & Medical Center25.810
Penn Presbyterian Medical Center25.810
Perelman Center for Advanced Medicine25.810
Scheie Eye Institute25.810
Seaver Autism Center25.810
Sharecare25.810
Sibley Memorial Hospital25.810
SkinCeuticals25.810
Sofia Frangou25.810
Stanford Hospital and Clinics25.810
Stanford University Medical Center25.810
The Whitney and Betty MacMillan Center for International and Area Studies at Yale25.810
Trumbull College25.810
UCSF Medical Center25.810
Michigan Medicine25.810
University of Pennsylvania Health System25.810
University of Washington Medical Center25.810
University of Washington School of Medicine25.810
Victor Velculescu25.810
WWAMI Regional Medical Education Program25.810
Wineburgh Philatelic Research Library25.810
Yale Sustainable Food Project25.810
Zocdoc25.810
Yale Divinity School25.810
Forbes' list of the world's highest-paid athletes25.810
Johns Hopkins Bayview Medical Center25.810
Cancer Control25.810
Yale Human Rights and Development Law Journal25.810
Journal of the American Academy of Dermatology25.810
Progress in Transplantation: the journal for procurement and clinical transplant professionals25.810
AIDS Reader25.810
Seminars in Neurology25.810
Journal of Clinical Hypertension25.810
Journal of Marine Research25.810
Translation Review25.810
Menachem Elimelech25.810
Q1611739025.810
Mohamed Mansour25.810
University of Texas at Dallas academic programs25.810
Icahn Institute for Genomics and Multiscale Biology25.810
Healthline25.810
Suburban Hospital25.810
MedicineNet25.810
Airlift Northwest25.810
Edward Thomas Ryan25.810
Ratemds.com25.810
Teladoc25.810
Bhavani Thuraisingham25.810
Dermstore25.810
William G. Nelson25.810
RealSelf25.810
Charles Limb25.810
Joseph John Klimek25.810
Hervé Abdi25.810
Forbes25.810
Cleveland Clinic Journal of Medicine25.810
Harvard heart letter : from Harvard Medical School25.810
Harvard health letter25.810
MedGenMed : Medscape general medicine25.810
Infections in medicine25.810
Skinmed25.810
FP essentials25.810
Marymount Hospital25.810
Sidney Kimmel Comprehensive Cancer Center25.810
Mayo Clinic Hospital25.810
A. Alfred Taubman Health Care Center25.810
Forefront of Dermatology25.810
Northwell Health Cancer Institute25.810
Huron Hospital25.810
Women's Hospital25.810
Harvard Affiliated Emergency Medicine Residency25.810
Cleveland Clinic Florida25.810
Melanoma Research Foundation25.810
National Rosacea Society25.810
Fotona (Slovenia)25.810
aspirin17.201
Morgellons17.201
classical genetics17.201
Karl Herxheimer17.201
acne17.201
dandruff17.201
psoriasis17.201
vitiligo17.201
melanoma17.201
skin cancer17.201
salicylic acid17.201
2-hydroxy-5-octanoylbenzoic acid17.201
3,5-dinitrosalicylic acid17.201
4-aminosalicylic acid17.201
4-hydroxybenzoic acid17.201
5-nitrosalicylic acid17.201
acne aestivalis17.201
balsalazide17.201
pseudofolliculitis barbae17.201
ethyl salicylate17.201
benzoyl peroxide17.201
acanthosis nigricans17.201
gentisic acid17.201
sulfasalazine17.201
phenyl salicylate17.201
chloracne17.201
equine sarcoid17.201
rash17.201
Acne conglobata17.201
basal-cell carcinoma of the skin17.201
rosacea17.201
toner17.201
personal lubricant17.201
skin disease17.201
intense pulsed light17.201
Dermoid sinus17.201
dermatographia17.201
discoid lupus erythematosus17.201
Poikiloderma17.201
salsalate17.201
cleanser17.201
Revlon17.201
Q147730917.201
hand eczema17.201
keratosis pilaris17.201
hypertrophic scar17.201
trench foot17.201
phytophotodermatitis17.201
kraurosis vulvae17.201
Merkel cell carcinoma17.201
Achenbach syndrome17.201
Livedo racemosa17.201
Mohs surgery17.201
sari cancer17.201
liquid bandage17.201
cheilitis granulomatosa17.201
Biotherm17.201
salicylamide17.201
kangaroo care17.201
diflunisal17.201
Alizarine Yellow R17.201
3-hydroxybenzoic acid17.201
Artistry17.201
Fitzpatrick scale17.201
chemical peel17.201
pulicosis17.201
salicylanilide17.201
Category:Skin cancer17.201
Occupational acne17.201
cystic acne17.201
systemic acquired resistance17.201
junctional epidermolysis bullosa17.201
X-linked ichthyosis17.201
NARS Cosmetics17.201
Copra itch17.201
grain itch17.201
EBooking17.201
Acne mechanica17.201
Acne miliaris necrotica17.201
Acne necrotica17.201
Acrogeria17.201
adapalene/benzoyl peroxide17.201
Aesop17.201
acetozone17.201
Amyloid purpura17.201
Aquaphor17.201
aurintricarboxylic acid17.201
Autoeczematization17.201
Aveeno17.201
Baker's itch17.201
multiple symmetric lipomatosis17.201
Benzamycin17.201
benzoyl peroxide/clindamycin17.201
Benzoyl peroxide17.201
Photorejuvenation17.201
Bronner Bros.17.201
Cetaphil17.201
Clarisonic17.201
Comedone extraction17.201
cupric salicylate17.201
anti-aging cream17.201
Dermatosis neglecta17.201
discrete papular lichen myxedematosus17.201
Ella Baché17.201
Equestrian perniosis17.201
Eruptive vellus hair cyst17.201
Etix17.201
Factitial lymphedema17.201
Freederm17.201
Gold Bond17.201
granuloma annulare in HIV disease17.201
Granulomatous facial dermatitis17.201
cutaneous squamous-cell carcinoma17.201
Idiopathic eruptive macular pigmentation17.201
Idiopathic facial aseptic granuloma17.201
Lichen aureus17.201
lichen striatus17.201
list of cutaneous conditions associated with increased risk of nonmelanoma skin cancer17.201
localized granuloma annulare17.201
Lycopenemia17.201
Miliary dermatitis17.201
Natural skin care17.201
Nicomide17.201
Notholaenic acid17.201
Oral melanosis17.201
Orthostatic purpura17.201
PUVA lentigines17.201
Pachydermatous eosinophilic dermatitis17.201
Papuloerythroderma of Ofuji17.201
Papulopustular17.201
patch-type granuloma annulare17.201
pathergy17.201
patient-centered care17.201
Perforating folliculitis17.201
perforating granuloma annulare17.201
periorbital dermatitis17.201
Phototoxic tar dermatitis17.201
pigmentation disorder17.201
Category:Deaths from skin cancer17.201
Pomade acne17.201
Preetika Rao17.201
Progressive symmetric erythrokeratodermia17.201
Pruritic folliculitis of pregnancy17.201
Sensitive Skin17.201
Sensitive Skin Magazine17.201
Sensitive skin17.201
Sensitive skin17.201
Sensitive skin type17.201
Category:Skin care17.201
Skin Cancer: Recognition and Management17.201
skin cancer in cats and dogs17.201
skin pop scar17.201
Titanium metallic discoloration17.201
trolamine salicylate17.201
ulnar-mammary syndrome17.201
Urticarial dermatoses17.201
Urticarial vasculitis17.201
Zosteriform speckled lentiginous nevus17.201
Category:Acne treatments17.201
Category:Skin cancer survivors17.201
Hees lotion17.201
Template:Skin tumors, nevi and melanomas17.201
OXY17.201
Hada Labo17.201
Cidesco17.201
tert-butyl peroxybenzoate17.201
Lisa Vanderpump17.201
Pechoin17.201
Halogen acne17.201
postinflammatory hyperpigmentation17.201
ClickBus17.201
Rachel K17.201
Sensitive Skin17.201
Gene therapy trial for skin cancer cures two terminal patients17.201
7+3 (chemotherapy)17.201
GolfNow17.201
FromAtoB.com17.201
Johnson's Baby17.201
skin carcinoma17.201
skin carcinoma in situ17.201
Christopher OBrien17.201
Zoe Foster Blake17.201
Skin care17.201
Synthetic plant defense elicitors17.201
Cauliflower mosaic virus protein P6 inhibits signaling responses to salicylic acid and regulates innate immunity17.201
ABO Blood Group and Incidence of Skin Cancer17.201
benzoyl peroxide exposure17.201
MRI-based treatment plan simulation and adaptation for ion radiotherapy using a classification-based approach17.201
Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study17.201
Co-synergism of endophyte Penicillium resedanum LK6 with salicylic acid helped Capsicum annuumin biomass recovery and osmotic stress mitigation17.201
Acne scars: pathogenesis, classification and treatment17.201
induced systemic resistance17.201
response to salicylic acid17.201
salicylic acid biosynthetic process17.201
NIOSH Method 5009: Benzoyl Peroxide17.201
Skin cancer in Australia17.201
Nonmelanoma Skin Cancer17.201
Epidemiology and Economic Burden of Nonmelanoma Skin Cancer17.201
detection of salicylic acid stimulus17.201
cellular response to salicylic acid stimulus17.201
regulation of salicylic acid mediated signaling pathway17.201
modulation by symbiont of host salicylic acid-mediated defense response17.201
positive regulation of systemic acquired resistance17.201
positive regulation by symbiont of host salicylic acid-mediated defense response17.201
modulation by symbiont of defense-related host salicylic acid-mediated signal transduction pathway17.201
induction by symbiont of defense-related host salicylic acid-mediated signal transduction pathway17.201
suppression by symbiont of defense-related host salicylic acid-mediated signal transduction pathway17.201
induction by symbiont of host induced systemic resistance17.201
induction by symbiont of host systemic acquired resistance17.201
modulation by symbiont of host systemic acquired resistance17.201
salicylic acid metabolic process17.201
salicylic acid catabolic process17.201
positive regulation of salicylic acid mediated signaling pathway17.201
regulation of salicylic acid metabolic process17.201
regulation of salicylic acid biosynthetic process17.201
salicylic acid mediated signaling pathway17.201
systemic acquired resistance, salicylic acid mediated signaling pathway17.201
modulation by symbiont of salicylic acid levels in host17.201
negative regulation by symbiont of salicylic acid levels in host17.201
salicylic acid binding17.201
methyl salicylate esterase activity17.201
salicylic acid glucosyltransferase (glucoside-forming) activity17.201
salicylic acid glucosyltransferase (ester-forming) activity17.201
Diviac17.201
American College of Mohs Surgery17.201
Kaya Limited17.201
Aveeno Baby product line17.201
EOS Products, LLC17.201
Developmental toxicity interactions of salicylic acid and radiofrequency radiation or 2-methoxyethanol in rats17.201
A case-control study of skin cancer in the tire and rubber manufacturing industry17.201
Comparison of Florida skin cancer screening rates with those in different US regions17.201
Teens teach skin cancer prevention17.201
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer17.201
Self-reported dermatitis and skin cancer in California farm operators17.201
Skin cancer prevention and detection practices in a Michigan farm population following an educational intervention17.201
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms17.201
Reported skin cancer screening of US adult workers17.201
Skin cancer epidemiological studies17.201
Interventions for acne scars17.201
Laser resurfacing for facial acne scars17.201
Interventions for acne scars17.201
Topical azelaic acid, salicylic acid, nicotinamide, and sulphur for acne17.201
Topical benzoyl peroxide for acne17.201
Educational programmes for primary prevention of skin cancer17.201
Topical retinoids for the treatment of acne vulgaris17.201
Skin-to-skin care for procedural pain in neonates17.201
Topical retinoids for the treatment of acne vulgaris17.201
Educational programmes for skin cancer prevention17.201
Topical retinoids for acne vulgaris17.201
Skin-to-skin care for procedural pain in neonates17.201
Chlorhexidine skin care for the prevention of infection in term neonates17.201
Topical retinoids for acne vulgaris17.201
Educational programmes for skin cancer prevention17.201
Oral antibiotics versus parenteral antibiotics for severe pneumonia in children17.201
Oral antibiotics versus parenteral antibiotics for severe pneumonia in children17.201
Phosphatidylinositol 4-kinase activation is an early response to salicylic acid in Arabidopsis suspension cells17.201
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer17.201
Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi17.201
A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q2317.201
Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans17.201
Salicylic acid-independent ENHANCED DISEASE SUSCEPTIBILITY1 signaling in Arabidopsis immunity and cell death is regulated by the monooxygenase FMO1 and the Nudix hydrolase NUDT717.201
The Role of Manganese Superoxide Dismutase in Skin Cancer17.201
Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City17.201
Nonsurgical innovations in the treatment of nonmelanoma skin cancer17.201
Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis17.201
Cytokinins mediate resistance against Pseudomonas syringae in tobacco through increased antimicrobial phytoalexin synthesis independent of salicylic acid signaling17.201
Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians17.201
IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer17.201
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris17.201
Realistic expectations of prepulse inhibition in translational models for schizophrenia research17.201
Suppressor role of activating transcription factor 2 (ATF2) in skin cancer17.201
Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system17.201
A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions17.201
Tropic Skin Care17.201
Differential role of basal keratinocytes in UV-induced immunosuppression and skin cancer17.201
Salicylic acid and NPR1 induce the recruitment of trans-activating TGA factors to a defense gene promoter in Arabidopsis17.201
A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction17.201
Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer17.201
Sunlight and Skin Cancer17.201
Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study17.201
A Model for UV-Induction of Skin Cancer17.201
Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study17.201
A model community skin cancer prevention project in Maine17.201
Digital diagnosis: new tool for detecting skin cancer17.201
Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics17.201
Using evidence-based community and behavioral interventions to prevent skin cancer: opportunities and challenges for public health practice.17.201
Identifying feed and seed stores as a site to promote skin cancer control: a social marketing approach to agricultural health communication17.201
Benzoyl peroxide - failure report17.201
SPORE - benzoyl peroxide17.201
Criteria for a recommended standard... occupational exposure to benzoyl peroxide17.201
NIOSH analytical method, benzoyl peroxide, S253, (Set 2)17.201
NIOSH analytical method, benzoyl peroxide, sampling data sheet, S253, (Set 2)17.201
NIOSH analytical method, benzoyl peroxide, backup data report, S253, (Set 2)17.201
Insect antimicrobial peptides: potential tools for the prevention of skin cancer17.201
Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer17.201
Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy17.201
Multiple Targets of Salicylic Acid and Its Derivatives in Plants and Animals17.201
The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer17.201
Circadian Dysrhythmias, Physiological Aberrations, and the Link to Skin Cancer17.201
Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy17.201
Clinical and Biological Principles of Cold Atmospheric Plasma Application in Skin Cancer17.201
COPD: the patient perspective17.201
Cutaneous Scar Prevention and Management: Overview of current therapies17.201
Potential Benefits of Omega-3 Fatty Acids in Non-Melanoma Skin Cancer17.201
Family Physician–Case Manager Collaboration and Needs of Patients With Dementia and Their Caregivers: A Systematic Mixed Studies Review17.201
Investigation of comparative effectiveness research in Asia, Europe, and North America17.201
Brachytherapy in the treatment of skin cancer: an overview17.201
Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy17.201
Brachytherapy in non melanoma skin cancer of eyelid: a systematic review17.201
Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris17.201
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors17.201
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer17.201
Sun-related behaviors among individuals previously diagnosed with non-melanoma skin cancer17.201
Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer17.201
Fillers for the improvement in acne scars17.201
Emerging Therapies for Scar Prevention17.201
Psychosocial Risk Factors, Interventions, and Comorbidity in Patients with Non-Specific Low Back Pain in Primary Care: Need for Comprehensive and Patient-Centered Care17.201
Dhoti cancer: a waistline skin cancer with review of literature17.201
Salicylic acid as a peeling agent: a comprehensive review17.201
Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines17.201
Interdisciplinary care clinics in chronic kidney disease17.201
Choice of Treatment Plan Based on Root Canal Therapy versus Extraction and Implant Placement: A Mini Review17.201
Relationship between Participation in Patient- and Family-Centered Care Training and Communication Adaptability among Medical Students: Changing Hearts, Changing Minds17.201
Salicylic acid-induced abiotic stress tolerance and underlying mechanisms in plants17.201
Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair17.201
Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition17.201
Skin care: Historical and contemporary views17.201
Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis17.201
Bringing Patient-Centered Care to the Fore in Diseases of the Pancreas17.201
Journal of Skin Cancer17.201
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?17.201
The mechanistic basis of arsenicosis: pathogenesis of skin cancer17.201
A conceptual model of the multiple stages of communication necessary to support patient-centered care17.201
Cytokinin cross-talking during biotic and abiotic stress responses17.201
The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection17.201
A systematic review of worldwide incidence of nonmelanoma skin cancer17.201
The role of the EP receptors for prostaglandin E2 in skin and skin cancer17.201
Patient-centered care for people living with multimorbidity17.201
Scoping review of patient-centered care approaches in healthcare17.201
The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives17.201
Patient-centered endodontic outcomes: a narrative review17.201
Signalling crosstalk in light stress and immune reactions in plants17.201
Skin Cancer Prevention among School Children: a Brief Review17.201
UV-induced occupational skin cancer: possibilities of secondary individual prevention in the "Dermatologist's Procedure"17.201
Drug Reaction, Skin Care, Skin Loss17.201
AHL-priming functions via oxylipin and salicylic acid17.201
Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles17.201
Treating perioperative anxiety and pain in children: a tailored and innovative approach17.201
Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars17.201
Improving adherence to acne treatment: the emerging role of application software17.201
Use of radiofrequency in cosmetic dermatology: focus on nonablative treatment of acne scars17.201
Cellular reprogramming in skin cancer17.201
3,5-dibromo-4-hydroxybenzoic acid17.201
isopropyl salicylate17.201
physostigmine salicylate17.201
3,5-dichloro-4-hydroxybenzoic acid17.201
valerylsalicylic acid17.201
2-(D-glucosyloxy)benzoic acid17.201
amyl salicylate17.201
trans-3-Hexenyl salicylate17.201
2-Ethylhexyl salicylate17.201
cis-3-Hexenyl salicylate17.201
3-aminosalicylic acid17.201
salicylic acid monoethanolamine17.201
dodecylamine salicylate17.201
eseridine salicylate17.201
nicotinatesalicylic acid17.201
bamipine salicylate17.201
5,5'-methylenedisalicyclic acid17.201
carbazochrome salicylate17.201
mordant yellow 1017.201
(E,E)-3,5-di-(4-(2-carboxyethylcarbamoyl)phenylazo)salicylic acid17.201
4-chlorosalicylic acid17.201
oxyquinoline salicylate17.201
benzydamine salicylate17.201
2-propionyloxybenzoic acid17.201
(E,E)-5-((2-(4-(2-carboxyethylcarbamoyl)phenylazo)-4-(2-carboxyethyl-carbamoyl)(phenylazo(salicylic acid))))17.201
(E)-3-(4-(2-carboxyethylcarbamoyl) phenylazo)-salicylic acid17.201
morpholine salicylate17.201
(E)-5-((3-(2-carboxyethylcarbamoyl)phenyl)azo(salicylic acid17.201
methyl salicylate 2-ethylbutyrate17.201
3-pyridylmethylamine salicylate17.201
citrosalic acid17.201
alizarine yellow R sodium17.201
2-hexanoyloxybenzoic acid17.201
salazosulfadimidine17.201
Large molecular systems landscape uncovers T cell trapping in human skin cancer17.201
Salicylic acid, a plant defense hormone, is specifically secreted by a molluscan herbivore17.201
How People with Facial Acne Scars are Perceived in Society: an Online Survey17.201
New Patient-Oriented Tools for Assessing Atrophic Acne Scarring17.201
Phospholipase D Activation Is an Early Component of the Salicylic Acid Signaling Pathway in Arabidopsis Cell Suspensions17.201
Structural Basis for Substrate Recognition in the Salicylic Acid Carboxyl Methyltransferase Family17.201
Iodination of salicylic acid improves its binding to transthyretin17.201
Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)17.201
Salicylic Acid Induces Mitochondrial Injury by Inhibiting Ferrochelatase Heme Biosynthesis Activity17.201
Antibiotic resistance in acne treatment17.201
diphenhydramine salicylate17.201
Associations among rotating night shift work, sleep and skin cancer in Nurses' Health Study II participants17.201
Detection of skin cancer by classification of Raman spectra17.201
Photodynamic Therapy and Non-Melanoma Skin Cancer17.201
Skin Cancer Prevention (PDQ®): Health Professional Version17.201
Skin Cancer Screening (PDQ®): Health Professional Version17.201
Skin Cancer Prevention (PDQ®): Patient Version17.201
Skin Cancer Treatment (PDQ®): Patient Version17.201
Patient-centered care interventions for the management of alcohol use disorders: a systematic review of randomized controlled trials17.201
Interventions to increase adherence to acne treatment17.201
The Danish Nonmelanoma Skin Cancer Dermatology Database17.201
Genetics of Skin Cancer (PDQ®): Health Professional Version17.201
New developments in acne treatment: role of combination adapalene-benzoylperoxide17.201
Skin Cancer Treatment (PDQ®): Health Professional Version17.201
Atrophic acne scarring: a review of treatment options17.201
Prediction of the Occurrence of Melanoma and Non-melanoma Skin Cancer in Patients with Vitiligo17.201
Cullin-RING ubiquitin ligases in salicylic acid-mediated plant immune signaling17.201
Perspectives on modern orthopaedics: use of Adcon-L for epidural scar prevention17.201
Neonatal skin care: the scientific basis for practice17.201
Cosmetics and skin care products. A historical perspective17.201
Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer17.201
Acetyl salicylic acid improves somatosensory evoked potentials in streptozotocin-diabetic rats17.201
Acetyl salicylic acid (aspirin), micronutrients and chloroquine in the management of the acquired immunodeficiency syndrome (AIDS)17.201
Role of salicylic acid in systemic resistance induced by Pseudomonas fluorescens against Fusarium oxysporum f. sp. ciceri in chickpea17.201
A rapid high-performance liquid chromatographic method for the simultaneous quantitation of aspirin, salicylic acid, and caffeine in effervescent tablets17.201
Q2816612317.201
Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia17.201
Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases17.201
Auditory sensitivity in rats exposed to toluene and/or acetyl salicylic acid17.201
Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect17.201
Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico17.201
Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis17.201
Inhibition of cardiac mitochondrial respiration by salicylic acid and acetylsalicylate17.201
Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma17.201
Flow-through UV spectrophotometric sensor for determination of (acetyl)salicylic acid in pharmaceutical preparations17.201
HLA-G in skin cancer: a wolf in sheep's clothing?17.201
Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon17.201
Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin17.201
Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer17.201
Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid17.201
Interactions of aspirin and salicylic acid with prednisolone for inhibition of lymphocyte proliferation17.201
pH-Metric logK calculations of famotidine, naproxen, nizatidine, ranitidine and salicylic acid17.201
UV Erythema Reducing Capacity of Mizolastine Compared to Acetyl-salicylic Acid or both Combined in Comparison to Indomethacin† ¶17.201
Salicylic acid in soups prepared from organically and non-organically grown vegetables17.201
Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes17.201
Zeta-crystallin displays strong selectivity for salicylic acid over aspirin17.201
Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts--systematic literature review and meta-analysis17.201
Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid17.201
Q2819353717.201
Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells17.201
Determination of aspirin and free salicylic acid in lysinipirine injection by high performance liquid chromatography17.201
Fast and single solid phase fluorescence spectroscopic batch procedure for (acetyl) salicylic acid determination in drug formulations17.201
Effect of castration on acetyl salicylic acid metabolism in rabbits17.201
Administration-time dependent effects of acetyl-salicylic acid on blood pressure in patients with mild essential hypertension17.201
Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients17.201
Separation of salicylic acid drugs by aqueous and nonaqueous capillary electrophoresis with conductance detector17.201
Determination of free salicylic acid in chewing aspirin tablets by HPLC17.201
Salicylic acid: an old dog, new tricks, and staphylococcal disease17.201
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus17.201
Effect of acetyl salicylic acid in drinking water on reproductive performance of Japanese quail (Coturnix coturnix japonica)17.201
Case studies: Use of salicylic acid (Avosil) and hydrogel (Avogel) in limiting scar formation17.201
Race-Specific Elicitors of Cladosporium fulvum Induce Changes in Cell Morphology and the Synthesis of Ethylene and Salicylic Acid in Tomato Plants Carrying the Corresponding Cf Disease Resistance Gene17.201
Skin care management: educational aspects17.201
Emblica cascading antioxidant: a novel natural skin care ingredient17.201
Role of vitamins in skin care17.201
Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987-200017.201
Human skin condition and its associations with nutrient concentrations in serum and diet17.201
Skin cancer after X-ray treatment for scalp ringworm17.201
Chemoprevention of skin cancer and photoaging17.201
Development of salicylic acid detector tube17.201
Isochorismate synthase is required to synthesize salicylic acid for plant defence17.201
Effect of salicylic acid on invasion of human vascular endothelial cells by Staphylococcus aureus17.201
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group17.201
Circulating salicylic acid is related to fruit and vegetable consumption in healthy subjects17.201
Salicylic acid, aspirin17.201
Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer17.201
Salicylic acid-induced inactivation of creatine kinase in the presence of lactoperoxidase and H2O217.201
In vitro enantioselective displacement of propranolol from protein binding sites by acetyl salicylic acid and salicylic acid17.201
Semi-micro column high-performance liquid chromatography with UV detection for quantification of aspirin and salicylic acid and its application to patients' sera administered with low-dose enteric-coated aspirin17.201
UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin17.201
Acetyl salicylic acid augments functional recovery following sciatic nerve crush in mice17.201
Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils17.201
Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy17.201
Measurement of salicylic acid in human serum using stable isotope dilution and gas chromatography-mass spectrometry17.201
Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation17.201
Quantifying solubility enhancement due to particle size reduction and crystal habit modification: case study of acetyl salicylic acid17.201
Synthesis and bioactivies of salicylic acid-g-chitosan derivatives17.201
Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment17.201
Inaccuracies in self-reported histories of non-melanoma skin cancer17.201
Derivative-ratio spectrophotometric method for the determination of ternary mixture of aspirin, paracetamol and salicylic acid17.201
Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts17.201
The effects of acetylic salicylic acid on heart rate variability in healthy subjects17.201
Salicylic acid regulates flowering time and links defence responses and reproductive development17.201
Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update17.201
Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer17.201
Skin care practices for newborns and infants: review of the clinical evidence for best practices17.201
Evidence-based skin care management in radiation therapy17.201
Patients meet technology: the newest in patient-centered care initiatives17.201
The benefits of implementing a new skin care protocol in nursing homes17.201
The validity of skin care protocols followed by women with breast cancer receiving external radiation17.201
Pay-for-performance principles that promote patient-centered care: an ethics manifesto17.201
Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm17.201
Skin Care17.201
Over-the-counter Acne Treatments: A Review17.201
Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer17.201
Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer17.201
Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution)17.201
Severe acne-like lesions caused by amineptine overdose17.201
Innovations in natural ingredients and their use in skin care17.201
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin17.201
European recommendations on the use of oral antibiotics for acne17.201
Expression of caspase-14 reduces tumorigenicity of skin cancer cells17.201
A review of perineal skin care protocols and skin barrier product use17.201
A survey of skin problems and skin care regimens in the elderly17.201
Severe acne due to chronic amineptine overdose17.201
An automated method for the simultaneous determination of salicylic acid and salicylazoiminopyridine in commercial salicylazosulphapyridine17.201
Comparative response of male rats to parathion and lindane: Histopathological and biochemical studies17.201
Acne vulgaris: treatment with topical benzoyl peroxide acetone gel17.201
Tetracycline-associated intracranial hypertension in an adolescent: A complication of systemic acne therapy17.201
Effect of benzoyl peroxide on two-stage oral carcinogenesis and gamma-glutamyl transpeptidase in hamsters17.201
Inhibition of benzoyl peroxide-mediated tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated skin of Sencar mice by antioxidants nordihydroguaiaretic acid and diallyl sulfide17.201
Chemistry of salicylic acid and anthranilic acid. IV. Synthesis of 6-chloro-5-sulfamoyl- and 6-chloro-3-sulfamoylanthranilic acid derivatives17.201
Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris17.201
Effect of 3, 5 dimethoxy salicylic acid (antithiamine) on transketolase activity in blood, brain & intestine of rats17.201
Hexachlorophene emulsions and antiseptic skin care of newborn infants17.201
Improved Colorimetric Determination of Salicylic Acid and Its Metabolites in Urine17.201
Dermatopharmacology of salicylic acid. II. Epidermal antihyperplastic effect of salicylic acid in animals17.201
Photodynamic therapy for nonmelanoma skin cancer17.201
A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne17.201
Evidence for a role of salicylic acid in the oxidative damage generated by NaCl and osmotic stress in Arabidopsis seedlings17.201
Free and conjugated benzoic acid in tobacco plants and cell cultures. Induced accumulation upon elicitation of defense responses and role as salicylic acid precursors17.201
A nuclear casein kinase 2 activity is involved in early events of transcriptional activation induced by salicylic acid in tobacco17.201
Salicylic acid and ethylene pathways are differentially activated in melon cotyledons by active or heat-denatured cellulase from Trichoderma longibrachiatum17.201
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics17.201
p53 codon 72 polymorphism and human papillomavirus associated skin cancer17.201
L-carnitine supplementation in patients with cystic acne on isotretinoin therapy17.201
A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy17.201
Repellent and antifeedant activity of salicylic acid and related compounds against the biting midge, Culicoides impunctatus (Diptera: Ceratopogonidae)17.201
Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function17.201
Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin17.201
Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice17.201
Use of Tanning Beds and Incidence of Skin Cancer17.201
Patient follow-up after participating in a beach-based skin cancer screening program17.201
Sentinel health event surveillance: skin cancer of the scrotum in New York State17.201
Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics17.201
Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States17.201
Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire17.201
medical uses of salicylic acid17.201
TIG3 Tumor Suppressor-Dependent Organelle Redistribution and Apoptosis in Skin Cancer Cells17.201
Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer17.201
Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression17.201
Dermatologist-level classification of skin cancer with deep neural networks17.201
Abscisic Acid Promotes Susceptibility to the Rice Leaf Blight Pathogen Xanthomonas oryzae pv oryzae by Suppressing Salicylic Acid-Mediated Defenses17.201
Pirfenidone Nanoparticles Improve Corneal Wound Healing and Prevent Scarring Following Alkali Burn17.201
Fermentation Products of Solvent Tolerant Marine Bacterium Moraxella spp. MB1 and Its Biotechnological Applications in Salicylic Acid Bioconversion17.201
“On-Off” Thermoresponsive Coating Agent Containing Salicylic Acid Applied to Maize Seeds for Chilling Tolerance17.201
Mitochondrial-Derived Reactive Oxygen Species Play a Vital Role in the Salicylic Acid Signaling Pathway in Arabidopsis thaliana17.201
Salicylic Acid Induces Changes in Mango Fruit that Affect Oviposition Behavior and Development of the Oriental Fruit Fly, Bactrocera dorsalis17.201
Human GAPDH Is a Target of Aspirin's Primary Metabolite Salicylic Acid and Its Derivatives17.201
Pro-Oxidant Role of Silibinin in DMBA/TPA Induced Skin Cancer: 1H NMR Metabolomic and Biochemical Study17.201
Quantitative Proteomic Profiling of Early and Late Responses to Salicylic Acid in Cucumber Leaves17.201
Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition17.201
Synergistic efficacy of salicylic acid with a penetration enhancer on human skin monitored by OCT and diffuse reflectance spectroscopy17.201
Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses17.201
Why are you here again? Concordance between consumers and providers about the primary concern in recurring psychiatric visits17.201
Skin cancer, irradiation, and sunspots: the solar cycle effect17.201
Molecular cloning of two novel peroxidases and their response to salt stress and salicylic acid in the living fossil Ginkgo biloba17.201
Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research17.201
Developing a data infrastructure for a learning health system: the PORTAL network17.201
PEDSnet: a National Pediatric Learning Health System17.201
Comparative study of normal and sensitive skin aerobic bacterial populations17.201
Using online health communities to deliver patient-centered care to people with chronic conditions17.201
Pediatric palliative care and eHealth opportunities for patient-centered care17.201
Dermatology undergraduate skin cancer training: a disconnect between recommendations, clinical exposure and competence17.201
Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis17.201
Impact of climate change on skin cancer17.201
EDR2 negatively regulates salicylic acid-based defenses and cell death during powdery mildew infections of Arabidopsis thaliana17.201
Shedding light on skin cancer17.201
Increase of Chamazulene and α-Bisabolol Contents of the Essential Oil of German Chamomile (Matricaria chamomilla L.) Using Salicylic Acid Treatments under Normal and Heat Stress Conditions17.201
A Case of Lichen Planus Pigmentosus with Facial Dyspigmentation Responsive to Combination Therapy with Chemical Peels and Topical Retinoids17.201
Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid17.201
Number and size of acquired melanocytic nevi and affecting risk factors in cases admitted to the dermatology clinic17.201
Iodine and Selenium Biofortification with Additional Application of Salicylic Acid Affects Yield, Selected Molecular Parameters and Chemical Composition of Lettuce Plants (Lactuca sativa L. var. capitata)17.201
Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer17.201
Degradation of the Plant Defense Signal Salicylic Acid Protects Ralstonia solanacearum from Toxicity and Enhances Virulence on Tobacco17.201
Richard Scolyer17.201
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans17.201
The chromatin remodeler DDM1 promotes hybrid vigor by regulating salicylic acid metabolism17.201
A Survey of Skin Problems and Skin Care Regimens in the Elderly17.201
Bolden17.201
Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer17.201
Treatment of Persistent Acne in Women with 17 Alpha Hydroxyprogesterone Caproate (Delalutin)17.201
Telephone calls to patients after discharge from the hospital: an important part of transitions of care17.201
Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India17.201
Skin cancer concerns particular to women17.201
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review17.201
Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence17.201
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches17.201
A systematic review of comorbidity indices used in the nonmelanoma skin cancer population17.201
Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review17.201
Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force17.201
Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis17.201
Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.17.201
Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon's Concern17.201
Michigan Center for Skin Care Research17.201
Long Island Skin Cancer and Dermatologic Surgery17.201
New York Laser and Skin Care17.201
Skin Care and Laser Physicians of Beverly Hills17.201
Impact of Patient-Centered Care Innovations on Access to Providers, Ambulatory Care Utilization, and Patient Clinical Indicators in the Veterans Health Administration17.201
Efficacy of an Intervention to Alter Skin Cancer Risk Behaviors in Young Adults.17.201
Development of an Internet Intervention to Address Behaviors Associated with Skin Cancer Risk among Young Adults17.201
Gold Skin Care Center17.201
Associated Skin Care Specialists17.201
Total body photography for skin cancer screening17.201
Patient-centered care, collaboration, communication, and coordination: a report from AMIA's 2013 Policy Meeting17.201
Realistic expectations for safety devices17.201
Can patients hospitalized with community-acquired pneumonia be treated safely and effectively with oral antibiotics?17.201
Perineal skin care for the incontinent patient17.201
Tender mercies: providing skin care for an incontinent patient17.201
Protecting perineal skin integrity. Incontinent patients present unique challenges to successful skin care management.17.201
E45 cream17.201
Bacteria-triggered systemic immunity in barley is associated with WRKY and ETHYLENE RESPONSIVE FACTORs but not with salicylic acid.17.201
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer17.201
PAMP-induced defense responses in potato require both salicylic acid and jasmonic acid.17.201
Salicylic acid is important for basal defense of Solanum tuberosum against Phytophthora infestans17.201
The role of salicylic acid and jasmonic acid in pathogen defence17.201
Making patient-centered care come alive: achieving full integration of the patient's perspective17.201
Incorporating skin care into a facial plastic surgery practice17.201
Improvement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract17.201
The patient-centered approach, a humanistic pathway for care17.201
Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need?17.201
Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need?17.201
Critical issues in clinical practice guidelines for geriatric care17.201
The effects of arts-in-medicine programming on the medical-surgical work environment17.201
The illusion of client-centred practice17.201
Application of the enabling occupation II guidelines in a non-Canadian context17.201
Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval17.201
Tools for “Decloaking” the Elephant in the Room: Conflict of Interest, Shared Decision-Making, and Patient-Centered Care17.201
Coordinating end of life care for individuals with a mental illness—A nurse practitioner collaboration17.201
Skin cancer prevention practices among malignant melanoma survivors: a systematic review17.201
Synergistic effect of antioxidant system and osmolyte in hydrogen sulfide and salicylic acid crosstalk-induced heat tolerance in maize (Zea mays L.) seedlings17.201
Person-centred care: an overview of reviews17.201
Arabidopsis thaliana GH3.5 acyl acid amido synthetase mediates metabolic crosstalk in auxin and salicylic acid homeostasis.17.201
The Nexus Between Patient-Centered Care and Complementary Medicine: Allies in the Era of Chronic Disease?17.201
An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective17.201
1,000 entitysAll results shown